Titan Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch TTNP and buy or sell other stocks, ETFs, and their options commission-free!About TTNP
Titan Pharmaceuticals, Inc. engages in the development of therapeutics for the treatment of chronic diseases utilizing its long-term, continuous drug delivery platform, proNeura. Its lead product is probuphine, a buprenorphine implant for the maintenance treatment of opioid addiction.
CEOWeei Jye Chay
CEOWeei Jye Chay
Employees—
Employees—
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded1992
Founded1992
Employees—
Employees—
TTNP Key Statistics
Market cap31.90M
Market cap31.90M
Price-Earnings ratio-1.56
Price-Earnings ratio-1.56
Dividend yield—
Dividend yield—
Average volume—
Average volume—
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$5.76
52 Week high$5.76
52 Week low$3.03
52 Week low$3.03
Stock Snapshot
With a market cap of 31.9M, Titan Pharmaceuticals(TTNP) trades at $23.98. The stock has a price-to-earnings ratio of -1.56.
On 2025-11-14, Titan Pharmaceuticals(TTNP) stock opened at —, reached a high of —, and a low of —.
Titan Pharmaceuticals(TTNP) shares are trading with a volume of 0.
During the past year, Titan Pharmaceuticals(TTNP) stock moved between $3.03 at its lowest and $5.76 at its peak.
During the past year, Titan Pharmaceuticals(TTNP) stock moved between $3.03 at its lowest and $5.76 at its peak.
People also own
Based on the portfolios of people who own TTNP. This list is generated using Robinhood data, and it’s not a recommendation.